Investigational Drug Information for Gossypol
✉ Email this page to a colleague
What is the drug development status for Gossypol?
Gossypol is an investigational drug.
There have been 10 clinical trials for Gossypol.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2013.
The most common disease conditions in clinical trials are Lung Neoplasms, Glioblastoma, and Small Cell Lung Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Mayo Clinic, and Sidney Kimmel Comprehensive Cancer Center.
Summary for Gossypol
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,951 |
| WIPO Patent Applications | 1,233 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 2 (2013-09-01) |
| Vendors | 107 |
Recent Clinical Trials for Gossypol
| Title | Sponsor | Phase |
|---|---|---|
| R-(-)-Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma | National Cancer Institute (NCI) | Phase 1 |
| R-(-)-Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma | Mayo Clinic | Phase 1 |
| Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia | National Cancer Institute (NCI) | Phase 1/Phase 2 |
Clinical Trial Summary for Gossypol
Top disease conditions for Gossypol
Top clinical trial sponsors for Gossypol
US Patents for Gossypol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
